González‐Félix et al., 2022 - Google Patents
Biological nanoparticles: Relevance as novel target drug delivery systems and leading chromatographic isolation approachesGonzález‐Félix et al., 2022
View PDF- Document ID
- 16311156148973923511
- Author
- González‐Félix M
- Mejía‐Manzano L
- González‐Valdez J
- Publication year
- Publication venue
- Electrophoresis
External Links
Snippet
Nanotechnology is one of the most promising technologies of the 21st century, and it is now presenting an enormous impact on target drug delivery. In this context, the recent use of natural vesicle‐like nanoparticles such as extracellular vesicles (ie, exosomes …
- 239000002105 nanoparticle 0 title abstract description 33
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bu et al. | Exosomes: isolation, analysis, and applications in cancer detection and therapy | |
| Alzhrani et al. | Exosomes: Isolation, characterization, and biomedical applications | |
| Villa et al. | Extracellular vesicles as natural, safe and efficient drug delivery systems | |
| Göpfrich et al. | One-pot assembly of complex giant unilamellar vesicle-based synthetic cells | |
| Dang et al. | Extracellular vesicles as an efficient and versatile system for drug delivery | |
| Wagner et al. | Asymmetric flow field-flow fractionation in the field of nanomedicine | |
| Yang et al. | Exosome biochemistry and advanced nanotechnology for next‐generation theranostic platforms | |
| Liu et al. | Extracellular vesicles: emerging tools as therapeutic agent carriers | |
| Perrault et al. | Virus-inspired membrane encapsulation of DNA nanostructures to achieve in vivo stability | |
| Schulz-Siegmund et al. | Nucleic acid delivery with extracellular vesicles | |
| Sen et al. | Exosomes as natural nanocarrier-based drug delivery system: recent insights and future perspectives | |
| Glasgow et al. | Osmolyte-mediated encapsulation of proteins inside MS2 viral capsids | |
| Gupta et al. | How corona formation impacts nanomaterials as drug carriers | |
| Bedi et al. | Targeted delivery of siRNA into breast cancer cells via phage fusion proteins | |
| Belhadj et al. | Current advances in non‐viral gene delivery systems: Liposomes versus extracellular vesicles | |
| Wu et al. | Aptamer-modified nanodrug delivery systems | |
| Zou et al. | Current knowledge and future perspectives of exosomes as nanocarriers in diagnosis and treatment of diseases | |
| Yang et al. | Single‐step equipment‐free extracellular vesicle concentration using super absorbent polymer beads | |
| Kang et al. | Cell‐released magnetic vesicles capturing metabolic labeled rare circulating tumor cells based on bioorthogonal chemistry | |
| Romano et al. | Exosomes in gliomas: biogenesis, isolation, and preliminary applications in nanomedicine | |
| González‐Félix et al. | Biological nanoparticles: Relevance as novel target drug delivery systems and leading chromatographic isolation approaches | |
| Pan et al. | Rapid and efficient isolation platform for plasma extracellular vesicles: EV‐FISHER | |
| Guo et al. | Immunomagnetic separation method integrated with the Strep-Tag II system for rapid enrichment and mild release of exosomes | |
| Rech et al. | Origin and composition of exosomes as crucial factors in designing drug delivery systems | |
| Oves et al. | Exosomes: a paradigm in drug development against cancer and infectious diseases |